Literature DB >> 28821430

Nrf2 regulates cellular behaviors and Notch signaling in oral squamous cell carcinoma cells.

Hong Fan1, Chorlada Paiboonrungruan2, Xinyan Zhang1, Justin R Prigge3, Edward E Schmidt3, Zheng Sun4, Xiaoxin Chen5.   

Abstract

Oxidative stress is known to play a pivotal role in the development of oral squamous cell carcinoma (OSCC). We have demonstrated that activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway has chemopreventive effects against oxidative stress-associated OSCC. However, Nrf2 have dual roles in cancer development; while it prevents carcinogenesis of normal cells, hyperactive Nrf2 also promotes the survival of cancer cells. This study is aimed to understand the function of Nrf2 in regulating cellular behaviors of OSCC cells, and the potential mechanisms through which Nrf2 facilitates OSCC. We established the Nrf2-overexpressing and Nrf2-knockdown OSCC cell lines, and examined the function of Nrf2 in regulating cell proliferation, migration, invasion, cell cycle and colony formation. Our data showed that Nrf2 overexpression promoted cancer phenotypes in OSCC cells, whereas Nrf2 silencing inhibited these phenotypes. In addition, Nrf2 positively regulated Notch signaling pathway in OSCC cells in vitro. Consistent with this observation, Nrf2 activation in Keap1-/- mice resulted in not only hyperproliferation of squamous epithelial cells in mouse tongue as evidenced by increased expression of PCNA, but also activation of Notch signaling in these cells as evidenced by increased expression of NICD1 and Hes1. In conclusion, Nrf2 regulates cancer behaviors and Notch signaling in OSCC cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Notch; Nrf2; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28821430      PMCID: PMC6037169          DOI: 10.1016/j.bbrc.2017.08.049

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.

Authors:  Tae-Hyoung Kim; Eu-gene Hur; Su-Jin Kang; Jung-Ae Kim; Dinesh Thapa; You Mie Lee; Sae Kwang Ku; Yunjin Jung; Mi-Kyoung Kwak
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

2.  Regulation of notch1 signaling by nrf2: implications for tissue regeneration.

Authors:  Nobunao Wakabayashi; Soona Shin; Stephen L Slocum; Elin S Agoston; Junko Wakabayashi; Mi-Kyoung Kwak; Vikas Misra; Shyam Biswal; Masayuki Yamamoto; Thomas W Kensler
Journal:  Sci Signal       Date:  2010-07-13       Impact factor: 8.192

3.  Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling.

Authors:  Manash K Paul; Bharti Bisht; Daphne O Darmawan; Richard Chiou; Vi L Ha; William D Wallace; Andrew T Chon; Ahmed E Hegab; Tristan Grogan; David A Elashoff; Jackelyn A Alva-Ornelas; Brigitte N Gomperts
Journal:  Cell Stem Cell       Date:  2014-06-19       Impact factor: 24.633

4.  Activation of the NOTCH pathway in head and neck cancer.

Authors:  Wenyue Sun; Daria A Gaykalova; Michael F Ochs; Elizabeth Mambo; Demetri Arnaoutakis; Yan Liu; Myriam Loyo; Nishant Agrawal; Jason Howard; Ryan Li; Sun Ahn; Elana Fertig; David Sidransky; Jeffery Houghton; Kalyan Buddavarapu; Tiffany Sanford; Ashish Choudhary; Will Darden; Alex Adai; Gary Latham; Justin Bishop; Rajni Sharma; William H Westra; Patrick Hennessey; Christine H Chung; Joseph A Califano
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

5.  Genetic analysis of cytoprotective functions supported by graded expression of Keap1.

Authors:  Keiko Taguchi; Jonathan M Maher; Takafumi Suzuki; Yukie Kawatani; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

7.  Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.

Authors:  Hironori Satoh; Takashi Moriguchi; Jun Takai; Masahito Ebina; Masayuki Yamamoto
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

8.  Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in squamous neoplasms.

Authors:  Kei Sakamoto; Takuma Fujii; Hiroshi Kawachi; Yoshio Miki; Ken Omura; Kei-ichi Morita; Kou Kayamori; Ken-ichi Katsube; Akira Yamaguchi
Journal:  Lab Invest       Date:  2012-02-13       Impact factor: 5.662

9.  Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.

Authors:  Tatsuhiro Shibata; Tsutomu Ohta; Kit I Tong; Akiko Kokubu; Reiko Odogawa; Koji Tsuta; Hisao Asamura; Masayuki Yamamoto; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

10.  Suppression of radiation-induced migration of non-small cell lung cancer through inhibition of Nrf2-Notch Axis.

Authors:  Qiuyue Zhao; Aihong Mao; Ruoshui Guo; Liping Zhang; Jiawei Yan; Chao Sun; Jinzhou Tang; Yancheng Ye; Yanshan Zhang; Hong Zhang
Journal:  Oncotarget       Date:  2017-05-30
View more
  9 in total

1.  Molecular biology of oral cavity squamous cell carcinoma.

Authors:  Phillip J Hsu; Kenneth Yan; Hailing Shi; Evgeny Izumchenko; Nishant Agrawal
Journal:  Oral Oncol       Date:  2020-01-07       Impact factor: 5.337

Review 2.  Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.

Authors:  Shaohua Ma; Chorlada Paiboonrungruan; Tiansheng Yan; Kevin P Williams; M Ben Major; Xiaoxin Luke Chen
Journal:  Ann N Y Acad Sci       Date:  2018-05-11       Impact factor: 5.691

3.  The triterpenoid corosolic acid blocks transformation and epigenetically reactivates Nrf2 in TRAMP-C1 prostate cells.

Authors:  Jie Yang; Renyi Wu; Wenji Li; Linbo Gao; Yuqing Yang; Ping Li; Ah-Ng Kong
Journal:  Mol Carcinog       Date:  2018-01-11       Impact factor: 4.784

4.  c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.

Authors:  Ya-Chu Tang; Jenn-Ren Hsiao; Shih-Sheng Jiang; Jang-Yang Chang; Pei-Yi Chu; Ko-Jiunn Liu; Hsun-Lang Fang; Li-Mei Lin; Huang-Hui Chen; Yen-Wen Huang; Yu-Tsen Chen; Fang-Yu Tsai; Su-Fang Lin; Yung-Jen Chuang; Ching-Chuan Kuo
Journal:  Theranostics       Date:  2021-03-11       Impact factor: 11.556

5.  Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma.

Authors:  Syed S Islam; Khawlah Qassem; Shafiqul Islam; Rashed R Parag; Mohammed Z Rahman; Walid A Farhat; Herman Yeger; Abdelilah Aboussekhra; Bedri Karakas; Abu Shadat M Noman
Journal:  Cell Death Dis       Date:  2022-08-09       Impact factor: 9.685

6.  Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway.

Authors:  Hui Liu; Xiaoliang Xu; Ran Wu; Lei Bi; Chunguang Zhang; Hui Chen; Yang Yang
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

Review 7.  The Role of Nrf2 Activity in Cancer Development and Progression.

Authors:  Alina-Andreea Zimta; Diana Cenariu; Alexandru Irimie; Lorand Magdo; Seyed Mohammad Nabavi; Atanas G Atanasov; Ioana Berindan-Neagoe
Journal:  Cancers (Basel)       Date:  2019-11-08       Impact factor: 6.639

8.  MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.

Authors:  Ran Wu; Weiwen Zuo; Xiaoliang Xu; Lei Bi; Chunguang Zhang; Hui Chen; Hui Liu
Journal:  Biomed Res Int       Date:  2021-06-03       Impact factor: 3.411

Review 9.  Nrf2 in the Field of Dentistry with Special Attention to NLRP3.

Authors:  Lisa Schieffer; Claudia Manzl; Christoph Schatz; Johannes Haybaeck; Adriano Crismani
Journal:  Antioxidants (Basel)       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.